We look at how micro- and nano-milling are transforming different sectors and preview Frewitt’s latest innovations.

In a U-turn from a decision two weeks ago, the FDA – citing new safety events – said the vaccine is a ‘danger to health’.

Analysts and charities have identified Gilead’s new HIV prevention injection as key to curbing infection rates ...

AbbVie has signed a definitive agreement to acquire Gilgamesh Pharmaceuticals' lead investigational candidate, bretisilocin, ...

Genentech, a member of the Roche Group, has commenced construction of a new manufacturing site in Holly Springs, North ...

Moderna has secured approval from Health Canada for Spikevax, its updated Covid-19 mRNA vaccine, which targets the SARS-CoV-2 ...

Cryo Store and Transposafe have announced the launch of the KelvinBox T900 series: the packaging solution for all your ...

Amid a push to phase out animal testing, Charles River’s Steve Bulera notes that the implementation of alternative methods ...

Tariff rates on generic pharmaceutical products imported from the EU to the US will now be “effectively zero or close to zero ...

Bavarian Nordic bolstered its cash reserves with a $160m sale of a priority review voucher in June 2025. The company has now ...

This webinar offers essential tools and insights to help organisations confidently navigate the BioSecure Act, ensuring they ...

Gilead will integrate Interius, the first biotech to push an in vivo CAR-T therapy into the clinic, into its cell therapy ...